Ltd.;Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.;Institute of Materia Medica, Chinese Academy of Medical Sciences;Jiangsu Tasly Diyi Pharmaceutical Co.
发明人:
Zhu, Haibo,Wang, Jing
申请号：
AU2017233089
公开号：
AU2017233089A1
申请日:
2017.03.10
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Provided are uses of an adenosine derivative, shown in formula (I), in preparing pharmaceuticals for the prevention and/or treatment of hyperlipidemia-induced monocytosis, and for the prevention and/or treatment of atherosclerosis. The prevention and/or treatment of atherosclerosis refers to the prevention and/or treatment of atherosclerosis-induced inflammatory monocytosis.
